Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis

Summary

Iododoxorubicin may dissolve protein deposits and be an effective treatment for primary systemic amyloidosis. Phase I trial to determine the effectiveness of iododoxorubicin in treating patients who have primary systemic amyloidosis

Timeline

Start

2001-12

Primary completion

2003-01

Completion

—

Outcome

Outcome not reported

Stopped: “Administratively complete.”

Drugs

Indications